2026 NPPES data Addiction Medicine (Internal Medicine) Physician NPI 1144311044 M.D.
Verify on CMS →

MICHAEL BISHARA, M.D.

Addiction Medicine (Internal Medicine) Physician in RIVERSIDE, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 132 beneficiaries · Addiction Medicine (Internal Medicine) Physician avg: 1K
Generic prescribing
91%
generic claims · 9% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$270.28
13 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MICHAEL BISHARA, M.D. filed 2,221 Medicare Part D claims in 2023 as a Addiction Medicine (Internal Medicine) Physician in RIVERSIDE, California, prescribing 91% generic.

2K
Part D claims, 2023
91%
generic prescribing
$270.28
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MICHAEL BISHARA, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

2,221 Top 15% higher than 85% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

MICHAEL BISHARA, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MICHAEL BISHARA, M.D.?

Quality data not reported

NPI registry status

Active

Issued 09/27/2006

NPI 1144311044

Primary specialty

Addiction Medicine (Internal Medicine) Physician

Niche

553 US NPIs in this specialty

Medicare Part D claims

2,221 58% vs specialty avg

2023 prescription claims

Specialty avg: 1,403

Specialty distribution in California

How Addiction Medicine (Internal Medicine) Physician compares to other specialties among California providers

California providers

Addiction Medicine (Internal Medicine) Physician share within California

1. Addiction Medicine (Internal Medicine) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Addiction Medicine (Internal Medicine) Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — Addiction Medicine (Internal Medicine) Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Addiction Medicine (Internal Medicine) Physician ABMS/AOA estimate

Est. board-certified rate (Addiction Medicine (Internal Medicine) Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Addiction Medicine (Internal Medicine) Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MICHAEL BISHARA, M.D. is a Addiction Medicine (Internal Medicine) Physician provider practicing in RIVERSIDE, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1144311044. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MICHAEL BISHARA, M.D. appears in the CMS NPPES registry as a Addiction Medicine (Internal Medicine) Physician provider holding M.D. credentials at 6896 MAGNOLIA AVE, RIVERSIDE, CA, 92506, with a listed phone of (951) 787-4885. NPI 1144311044 was issued on 09/27/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BISHARA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,221 prescription claims written by this provider, covering 132 Medicare beneficiaries and totaling roughly $260K in drug spend, split 9% brand-name and 91% generic by claim count, with an opioid prescribing rate of 1.9%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Addiction Medicine (Internal Medicine) Physician is a narrow specialty nationwide, with 553 enrolled providers across 46 states and an average of 1,403 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

6896 MAGNOLIA AVE
RIVERSIDE, CA 92506

Provider Details

NPI 1144311044
Specialty Addiction Medicine (Internal Medicine) Physician
Credentials M.D.
Gender Male
NPI Issued 09/27/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MICHAEL BISHARA, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$270

Largest payer

Braeburn Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to MICHAEL BISHARA, M.D.. To verify MICHAEL BISHARA, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

MICHAEL BISHARA, M.D. — brand share 9.0%
Specialty average (est.)

9% brand-name claims vs 91% generic, on 2,221 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,221
Total Claims
$260K
Total Drug Cost
132
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
3,429
Total Day Supply
97,983
Brand vs Generic
9% brand / 91% generic
Brand Drug Cost
$143K
Generic Drug Cost
$116K
Opioid Claims
43 (1.9% rate)
Antibiotic Claims
33

Patient Demographics

Average Patient Age
66.6 years
Avg HCC Risk Score
2.09
Gender Split
52% female / 48% male
Age Distribution
<65: 42, 65-74: 65, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Buprenorphine-Naloxone
Buprenorphine Hcl/Naloxone Hcl
279
Buprenorphine Hcl
61
Atorvastatin Calcium
60
Lisinopril
59
Atenolol
55
Amlodipine Besylate
54
Ibuprofen
44
Gabapentin
43
Methocarbamol
43
Pantoprazole Sodium
43

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Addiction Medicine (Internal Medicine) Physician Overview

How MICHAEL BISHARA, M.D. fits within the Addiction Medicine (Internal Medicine) Physician landscape nationally.

553
Addiction Medicine (Internal Medicine) Physician Providers in US
46
States with Addiction Medicine (Internal Medicine) Physician
1,403
Avg Claims per Provider

MICHAEL BISHARA, M.D.'s 2,221 claims are above the specialty average of 1,403.

Nearby Addiction Medicine (Internal Medicine) Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as BISHARA.

Compare Addiction Medicine (Internal Medicine) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MICHAEL BISHARA, M.D.'s specialty?
MICHAEL BISHARA, M.D. specializes in Addiction Medicine (Internal Medicine) Physician and practices in RIVERSIDE, California. Credentials: M.D..
How much does MICHAEL BISHARA, M.D. prescribe under Medicare Part D?
In 2023, MICHAEL BISHARA, M.D. wrote 2,221 Medicare Part D claims totaling $260K in drug costs for 132 beneficiaries.
Where is MICHAEL BISHARA, M.D. located?
MICHAEL BISHARA, M.D. is located at 6896 MAGNOLIA AVE, RIVERSIDE, CA, 92506. Phone: (951) 787-4885.
What is MICHAEL BISHARA, M.D.'s NPI number?
MICHAEL BISHARA, M.D.'s National Provider Identifier (NPI) is 1144311044, issued on 09/27/2006.
Does MICHAEL BISHARA, M.D. prescribe more brand-name or generic drugs?
MICHAEL BISHARA, M.D.'s prescribing is 9% brand-name and 91% generic drugs by claim count, with $143K in brand drug costs.
Does MICHAEL BISHARA, M.D. prescribe opioids?
Yes, MICHAEL BISHARA, M.D. had 43 opioid claims in 2023 with an opioid prescribing rate of 1.9%.
How many Addiction Medicine (Internal Medicine) Physician providers are there in the US?
There are 553 Addiction Medicine (Internal Medicine) Physician providers across 46 states in the US. The average Addiction Medicine (Internal Medicine) Physician provider writes 1,403 Medicare Part D claims per year.
What drugs does MICHAEL BISHARA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MICHAEL BISHARA, M.D.'s most frequently prescribed drugs include Buprenorphine-Naloxone, Buprenorphine Hcl, Atorvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MICHAEL BISHARA, M.D. accept Medicare?
MICHAEL BISHARA, M.D. appears in CMS Medicare data with 2,221 Part D claims and 132 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MICHAEL BISHARA, M.D.'s credentials?
MICHAEL BISHARA, M.D.'s NPI is 1144311044 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology